Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Bart Vanderborght

Faculty of Medicine and Health Sciences > Department of Internal Medicine and Pediatrics

Show Sort by

Add to list
- Journal Article
- A1
- open access
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

Eva Gijbels (UGent) , Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Tim Meese (UGent) , Filip Van Nieuwerburgh (UGent) , Aude Vanlander, Frederik Berrevoet (UGent) , Bart Hendrikx (UGent) , Anne Hoorens (UGent) , Hans Van Vlierberghe (UGent) , et al.

(2023) GENES & DISEASES. 10(1). p.18-21
Add to list
Kupffer cells contested as early drivers in the pathogenesis of primary sclerosing cholangitis

Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Federico Francesco De Ponti (UGent) , Eva Gijbels (UGent) , Sophie Van Welden (UGent) , Martin Guilliams (UGent) , Charlotte Scott (UGent) , Alain Beschin, Mathieu Vinken, Sander Lefere (UGent) , et al.

(2023) AMERICAN JOURNAL OF PATHOLOGY. 193(4). p.366-379
Add to list
- PhD Thesis
- open access
Targeting angiogenic and inflammatory components of the tumor microenvironment in hepatocellular carcinoma

Bart Vanderborght (UGent)

(2022)
Add to list
- Journal Article
- A1
- open access
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

Martin Guilliams (UGent) , Johnny Bonnardel (UGent) , Birthe Haest (UGent) , Bart Vanderborght (UGent) , Camille Wagner (UGent) , Anneleen Remmerie (UGent) , Anna Bujko (UGent) , Liesbet Martens (UGent) , Tinne Thoné (UGent) , Robin Browaeys (UGent) , et al.

(2022) CELL. 185(2). p.379-396
Add to list
- Journal Article
- A2
- open access
Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models

Helena Degroote (UGent) , Sander Lefere (UGent) , Astrid Vandierendonck, Bart Vanderborght (UGent) , Tim Meese (UGent) , Filip Van Nieuwerburgh (UGent) , Xavier Verhelst (UGent) , Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2021) ONCOTARGET. 12(6). p.562-577
Add to list
- Journal Article
- A1
- open access
The gut–liver axis in chronic liver disease : a macrophage perspective

Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2021) CELLS. 10(11).
Add to list
- Journal Article
- A1
- open access
In vivo and in vitro models of hepatocellular carcinoma : current strategies for translational modeling

Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght (UGent) , Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher (UGent) , Niels Olsen Saraiva Câmara, et al.

(2021) CANCERS. 13(21).
Add to list
- Journal Article
- A1
- open access
NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma

Aster Vandierendonck (UGent) , Helena Degroote (UGent) , Bart Vanderborght (UGent) , Xavier Verhelst (UGent) , Anja Geerts (UGent) , Lindsey Devisscher (UGent) and Hans Van Vlierberghe (UGent)

(2021) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 40(1).
Add to list
- Journal Article
- A2
- open access
Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model

Bart Vanderborght (UGent) , Kevin De Muynck (UGent) , Sander Lefere (UGent) , Anja Geerts (UGent) , Helena Degroote (UGent) , Xavier Verhelst (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2020) ONCOTARGET. 11(48). p.4504-4520
Add to list
- Journal Article
- A1
- open access
The angiopoietin/tie2 pathway in hepatocellular carcinoma

Bart Vanderborght (UGent) , Sander Lefere (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2020) CELLS. 9(11).